Perhaps even more than past breakthroughs, the novel COVID-19 mRNA vaccines have inspired immediate and widespread relief and optimism. Biomedical scientists labored for decades to develop the expertise and proof of feasibility that led to the vaccines; this innovative work has saved countless lives and promises an end to a pandemic that has killed millions … Continued
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology. The findings, published in Science Immunology, suggest only a single vaccine dose may be needed to produce a sufficient antibody … Continued
Many long for a return to a post-pandemic “normal,” which, for some, may entail concerts, travel, and large gatherings. But how to keep safe amid these potential public health risks? One possibility, according to a new study led by the UPenn School of Veterinary Medicine, is dogs. A proof-of-concept investigation published today in the journal … Continued
A how-to guide from Penn Medicine helps others address vaccine distribution inequities via community vaccine clinics.
People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new research from the Penn Institute of Immunology.
By the year 2017, the United States was already suffering more excess deaths and more life years lost each year than those associated with the COVID-19 pandemic in 2020, according to research from demographers Samuel Preston of the University of Pennsylvania and Yana Vierboom of the Max Planck Institute for Demographic Research.
Different communities have different reasons for wanting to wait on this shot. Getting to the heart of those concerns can help meet people where they are.
Nationwide, the rollout for the COVID-19 vaccine has been inequitable, with white individuals being vaccinated at higher rates compared to Black individuals. In Philadelphia, only 21 percent of the vaccine had gone to Black residents by March 2021, even though this group makes up 42 percent of the city’s population.
Despite the rising number of immunizations, more than a third of recent COVID-19 cases in the Philadelphia area are caused by concerning variants of the virus, according to a new analysis from a sample of patients from late February and early March conducted by Penn Medicine researchers.
CORONA is the world′s largest database of COVID-19 treatments, covering 400+ treatments that have been reported to be administered to 340,000+ patients, helping researchers to identify and prioritize promising treatments for well-designed clinical trials and to inform patient care.